Swedbank AB »

Halozyme Therapeutics shares owned by Swedbank AB

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Swedbank AB from 13F filings

Historical chart of Swedbank AB investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Swedbank AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Swedbank AB

Quarter filed Position value Share count Share price at filing
2024-12-31 $14M 283k 47.81
2024-09-30 $18M 318k 57.24
2024-06-30 $17M 332k 52.36
2024-03-31 $14M 342k 40.68
2023-12-31 $15M 415k 36.96
2023-09-30 $16M 406k 38.20
2023-06-30 $16M 441k 36.07
2023-03-31 $17M 441k 38.19
2022-12-31 $36M 630k 56.90
2022-09-30 $25M 640k 39.54
2022-06-30 $55M 1.2M 44.00
2022-03-31 $80M 2.0M 39.88
2021-12-31 $73M 1.8M 40.32
2021-09-30 $61M 1.5M 40.68
2021-06-30 $44M 970k 45.41
2021-03-31 $35M 847k 41.69